nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A7—Rifampicin—leprosy	0.102	0.147	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.102	0.147	CbGbCtD
Risperidone—CYP3A7—Dapsone—leprosy	0.084	0.121	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Dapsone—leprosy	0.084	0.121	CbGbCtD
Risperidone—CYP3A5—Thalidomide—leprosy	0.0788	0.114	CbGbCtD
Risperidone—CYP3A5—Rifampicin—leprosy	0.0764	0.11	CbGbCtD
Risperidone—CYP3A5—Dapsone—leprosy	0.063	0.0908	CbGbCtD
Risperidone—ABCB1—Rifampicin—leprosy	0.0497	0.0716	CbGbCtD
Risperidone—CYP3A4—Rifampicin—leprosy	0.0298	0.0429	CbGbCtD
Risperidone—CYP3A4—Dapsone—leprosy	0.0246	0.0354	CbGbCtD
Risperidone—HTR1B—trigeminal nerve—leprosy	0.00767	0.0806	CbGeAlD
Risperidone—HTR1D—trigeminal nerve—leprosy	0.00743	0.078	CbGeAlD
Risperidone—HRH1—nose—leprosy	0.00563	0.0591	CbGeAlD
Risperidone—HTR1B—cranial nerve—leprosy	0.00547	0.0574	CbGeAlD
Risperidone—HTR1D—cranial nerve—leprosy	0.00529	0.0556	CbGeAlD
Risperidone—HTR7—cranial nerve—leprosy	0.00422	0.0443	CbGeAlD
Risperidone—HTR2A—trigeminal nerve—leprosy	0.00369	0.0387	CbGeAlD
Risperidone—DRD1—nerve—leprosy	0.00346	0.0363	CbGeAlD
Risperidone—HTR7—peripheral nervous system—leprosy	0.00277	0.0291	CbGeAlD
Risperidone—HTR2A—cranial nerve—leprosy	0.00263	0.0276	CbGeAlD
Risperidone—HTR2A—hindlimb—leprosy	0.00222	0.0233	CbGeAlD
Risperidone—HTR1B—blood vessel—leprosy	0.0022	0.0231	CbGeAlD
Risperidone—HTR7—nerve—leprosy	0.00216	0.0227	CbGeAlD
Risperidone—HTR1D—blood vessel—leprosy	0.00213	0.0224	CbGeAlD
Risperidone—DRD2—nerve—leprosy	0.00204	0.0215	CbGeAlD
Risperidone—ADRA2A—peripheral nervous system—leprosy	0.00203	0.0213	CbGeAlD
Risperidone—HTR2A—appendage—leprosy	0.0019	0.02	CbGeAlD
Risperidone—White blood cell count decreased—Thalidomide—leprosy	0.00175	0.00832	CcSEcCtD
Risperidone—HTR2A—peripheral nervous system—leprosy	0.00173	0.0181	CbGeAlD
Risperidone—Transient ischaemic attack—Thalidomide—leprosy	0.00173	0.0082	CcSEcCtD
Risperidone—Lymphopenia—Thalidomide—leprosy	0.0017	0.00809	CcSEcCtD
Risperidone—HTR7—blood vessel—leprosy	0.0017	0.0178	CbGeAlD
Risperidone—Nuchal rigidity—Thalidomide—leprosy	0.00168	0.00798	CcSEcCtD
Risperidone—Skin exfoliation—Dapsone—leprosy	0.00163	0.00772	CcSEcCtD
Risperidone—DRD4—testis—leprosy	0.00157	0.0165	CbGeAlD
Risperidone—Sexual dysfunction—Thalidomide—leprosy	0.00156	0.00738	CcSEcCtD
Risperidone—Suicide attempt—Thalidomide—leprosy	0.00154	0.00729	CcSEcCtD
Risperidone—Gastric ulcer—Thalidomide—leprosy	0.0015	0.00712	CcSEcCtD
Risperidone—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.0015	0.00712	CcSEcCtD
Risperidone—Platelet count decreased—Thalidomide—leprosy	0.00147	0.00696	CcSEcCtD
Risperidone—Enlargement abdomen—Thalidomide—leprosy	0.00145	0.00688	CcSEcCtD
Risperidone—Toothache—Thalidomide—leprosy	0.00143	0.0068	CcSEcCtD
Risperidone—Deep vein thrombosis—Thalidomide—leprosy	0.00143	0.0068	CcSEcCtD
Risperidone—Psoriasis—Thalidomide—leprosy	0.00139	0.00658	CcSEcCtD
Risperidone—Hypothyroidism—Thalidomide—leprosy	0.00136	0.00645	CcSEcCtD
Risperidone—HTR2A—nerve—leprosy	0.00135	0.0141	CbGeAlD
Risperidone—Tooth disorder—Thalidomide—leprosy	0.00134	0.00638	CcSEcCtD
Risperidone—Galactorrhoea—Thalidomide—leprosy	0.00134	0.00638	CcSEcCtD
Risperidone—Intestinal obstruction—Thalidomide—leprosy	0.00128	0.00607	CcSEcCtD
Risperidone—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00128	0.00607	CcSEcCtD
Risperidone—Menstrual disorder—Thalidomide—leprosy	0.00128	0.00607	CcSEcCtD
Risperidone—H1F0—skin of body—leprosy	0.00127	0.0134	CbGeAlD
Risperidone—Hepatomegaly—Thalidomide—leprosy	0.00123	0.00585	CcSEcCtD
Risperidone—Metrorrhagia—Thalidomide—leprosy	0.00122	0.00579	CcSEcCtD
Risperidone—Hyperlipidaemia—Thalidomide—leprosy	0.00121	0.00574	CcSEcCtD
Risperidone—Psychotic disorder—Dapsone—leprosy	0.00121	0.00573	CcSEcCtD
Risperidone—Stupor—Thalidomide—leprosy	0.00117	0.00554	CcSEcCtD
Risperidone—HTR1D—eye—leprosy	0.00113	0.0119	CbGeAlD
Risperidone—Skin ulcer—Thalidomide—leprosy	0.00112	0.00532	CcSEcCtD
Risperidone—Nasopharyngitis—Dapsone—leprosy	0.00111	0.00525	CcSEcCtD
Risperidone—Muscular weakness—Dapsone—leprosy	0.00109	0.00518	CcSEcCtD
Risperidone—DRD3—nervous system—leprosy	0.00109	0.0114	CbGeAlD
Risperidone—Myocardial ischaemia—Thalidomide—leprosy	0.00109	0.00515	CcSEcCtD
Risperidone—Influenza—Dapsone—leprosy	0.00107	0.00507	CcSEcCtD
Risperidone—HTR2A—blood vessel—leprosy	0.00106	0.0111	CbGeAlD
Risperidone—Numbness—Thalidomide—leprosy	0.00105	0.00499	CcSEcCtD
Risperidone—Endocrine disorder—Thalidomide—leprosy	0.00105	0.00499	CcSEcCtD
Risperidone—Pancreatitis—Dapsone—leprosy	0.00105	0.00497	CcSEcCtD
Risperidone—Blood disorder—Thalidomide—leprosy	0.00104	0.00495	CcSEcCtD
Risperidone—Acne—Thalidomide—leprosy	0.00104	0.00492	CcSEcCtD
Risperidone—Apnoea—Thalidomide—leprosy	0.00103	0.00488	CcSEcCtD
Risperidone—Sensory loss—Thalidomide—leprosy	0.00101	0.00478	CcSEcCtD
Risperidone—Amenorrhoea—Thalidomide—leprosy	0.000993	0.00471	CcSEcCtD
Risperidone—Photosensitivity reaction—Dapsone—leprosy	0.000976	0.00463	CcSEcCtD
Risperidone—Musculoskeletal stiffness—Thalidomide—leprosy	0.000972	0.00461	CcSEcCtD
Risperidone—H1F0—tendon—leprosy	0.000969	0.0102	CbGeAlD
Risperidone—Viral infection—Thalidomide—leprosy	0.000966	0.00458	CcSEcCtD
Risperidone—Skin discolouration—Thalidomide—leprosy	0.000966	0.00458	CcSEcCtD
Risperidone—Bone disorder—Thalidomide—leprosy	0.000966	0.00458	CcSEcCtD
Risperidone—Arthropathy—Thalidomide—leprosy	0.000959	0.00455	CcSEcCtD
Risperidone—Cellulitis—Thalidomide—leprosy	0.000959	0.00455	CcSEcCtD
Risperidone—Hyperbilirubinaemia—Thalidomide—leprosy	0.000959	0.00455	CcSEcCtD
Risperidone—Thinking abnormal—Thalidomide—leprosy	0.000953	0.00452	CcSEcCtD
Risperidone—Hyperuricaemia—Thalidomide—leprosy	0.00094	0.00446	CcSEcCtD
Risperidone—Neuropathy peripheral—Dapsone—leprosy	0.000934	0.00443	CcSEcCtD
Risperidone—Leukocytosis—Thalidomide—leprosy	0.000928	0.0044	CcSEcCtD
Risperidone—Dyskinesia—Thalidomide—leprosy	0.000928	0.0044	CcSEcCtD
Risperidone—Hypercholesterolaemia—Thalidomide—leprosy	0.000922	0.00437	CcSEcCtD
Risperidone—HTR2B—skin of body—leprosy	0.000917	0.00963	CbGeAlD
Risperidone—Hearing impaired—Thalidomide—leprosy	0.000916	0.00435	CcSEcCtD
Risperidone—Bone pain—Thalidomide—leprosy	0.000911	0.00432	CcSEcCtD
Risperidone—Atrioventricular block—Thalidomide—leprosy	0.000899	0.00427	CcSEcCtD
Risperidone—Sinusitis—Dapsone—leprosy	0.000894	0.00424	CcSEcCtD
Risperidone—Gait disturbance—Thalidomide—leprosy	0.000894	0.00424	CcSEcCtD
Risperidone—Blood uric acid increased—Thalidomide—leprosy	0.000888	0.00421	CcSEcCtD
Risperidone—Coordination abnormal—Thalidomide—leprosy	0.000888	0.00421	CcSEcCtD
Risperidone—Neck pain—Thalidomide—leprosy	0.000883	0.00419	CcSEcCtD
Risperidone—Pulmonary embolism—Thalidomide—leprosy	0.000872	0.00414	CcSEcCtD
Risperidone—Hepatocellular injury—Thalidomide—leprosy	0.000872	0.00414	CcSEcCtD
Risperidone—Eructation—Thalidomide—leprosy	0.000857	0.00407	CcSEcCtD
Risperidone—DRD2—eye—leprosy	0.000854	0.00896	CbGeAlD
Risperidone—Pharyngitis—Dapsone—leprosy	0.000849	0.00403	CcSEcCtD
Risperidone—Depressed level of consciousness—Thalidomide—leprosy	0.000842	0.004	CcSEcCtD
Risperidone—Colitis—Thalidomide—leprosy	0.000837	0.00397	CcSEcCtD
Risperidone—ADRA1B—nervous system—leprosy	0.000834	0.00876	CbGeAlD
Risperidone—Skin exfoliation—Thalidomide—leprosy	0.000833	0.00395	CcSEcCtD
Risperidone—Dry eye—Thalidomide—leprosy	0.000806	0.00382	CcSEcCtD
Risperidone—H1F0—testis—leprosy	0.000803	0.00843	CbGeAlD
Risperidone—Cramps of lower extremities—Thalidomide—leprosy	0.000801	0.0038	CcSEcCtD
Risperidone—Tinnitus—Dapsone—leprosy	0.000798	0.00378	CcSEcCtD
Risperidone—Oesophagitis—Thalidomide—leprosy	0.000797	0.00378	CcSEcCtD
Risperidone—Rash maculo-papular—Thalidomide—leprosy	0.000793	0.00376	CcSEcCtD
Risperidone—H1F0—nervous system—leprosy	0.000788	0.00827	CbGeAlD
Risperidone—Gynaecomastia—Thalidomide—leprosy	0.00078	0.0037	CcSEcCtD
Risperidone—DRD1—nervous system—leprosy	0.000778	0.00817	CbGeAlD
Risperidone—Pulmonary oedema—Thalidomide—leprosy	0.000776	0.00368	CcSEcCtD
Risperidone—Hypertonia—Thalidomide—leprosy	0.000765	0.00363	CcSEcCtD
Risperidone—Hyperkinesia—Thalidomide—leprosy	0.000761	0.00361	CcSEcCtD
Risperidone—Mental disability—Thalidomide—leprosy	0.000757	0.00359	CcSEcCtD
Risperidone—Sepsis—Thalidomide—leprosy	0.000757	0.00359	CcSEcCtD
Risperidone—Euphoric mood—Thalidomide—leprosy	0.000749	0.00356	CcSEcCtD
Risperidone—Erythema—Dapsone—leprosy	0.000745	0.00353	CcSEcCtD
Risperidone—Lymphadenopathy—Thalidomide—leprosy	0.000742	0.00352	CcSEcCtD
Risperidone—Thrombophlebitis—Thalidomide—leprosy	0.000731	0.00347	CcSEcCtD
Risperidone—Diabetes mellitus—Thalidomide—leprosy	0.000728	0.00345	CcSEcCtD
Risperidone—Photosensitivity—Thalidomide—leprosy	0.000721	0.00342	CcSEcCtD
Risperidone—Gastroenteritis—Thalidomide—leprosy	0.000714	0.00339	CcSEcCtD
Risperidone—Vascular purpura—Thalidomide—leprosy	0.000708	0.00336	CcSEcCtD
Risperidone—Deafness—Thalidomide—leprosy	0.000708	0.00336	CcSEcCtD
Risperidone—Eczema—Thalidomide—leprosy	0.000705	0.00334	CcSEcCtD
Risperidone—Vision blurred—Dapsone—leprosy	0.000702	0.00333	CcSEcCtD
Risperidone—Eye pain—Thalidomide—leprosy	0.000701	0.00333	CcSEcCtD
Risperidone—HTR2B—tendon—leprosy	0.000698	0.00733	CbGeAlD
Risperidone—ABCB1—blood vessel—leprosy	0.000693	0.00728	CbGeAlD
Risperidone—Renal failure acute—Thalidomide—leprosy	0.000686	0.00325	CcSEcCtD
Risperidone—Libido decreased—Thalidomide—leprosy	0.000683	0.00324	CcSEcCtD
Risperidone—HRH1—eye—leprosy	0.000674	0.00708	CbGeAlD
Risperidone—Increased appetite—Thalidomide—leprosy	0.000674	0.0032	CcSEcCtD
Risperidone—Amnesia—Thalidomide—leprosy	0.000674	0.0032	CcSEcCtD
Risperidone—Vertigo—Dapsone—leprosy	0.000669	0.00317	CcSEcCtD
Risperidone—Atrial fibrillation—Thalidomide—leprosy	0.000668	0.00317	CcSEcCtD
Risperidone—Dermatitis bullous—Thalidomide—leprosy	0.000662	0.00314	CcSEcCtD
Risperidone—Purpura—Thalidomide—leprosy	0.000657	0.00312	CcSEcCtD
Risperidone—Arthritis—Thalidomide—leprosy	0.000651	0.00309	CcSEcCtD
Risperidone—Cough—Dapsone—leprosy	0.00065	0.00308	CcSEcCtD
Risperidone—Hypoglycaemia—Thalidomide—leprosy	0.000649	0.00308	CcSEcCtD
Risperidone—Lethargy—Thalidomide—leprosy	0.000646	0.00307	CcSEcCtD
Risperidone—Cerebrovascular accident—Thalidomide—leprosy	0.000646	0.00307	CcSEcCtD
Risperidone—Hyponatraemia—Thalidomide—leprosy	0.000636	0.00302	CcSEcCtD
Risperidone—Diplopia—Thalidomide—leprosy	0.000633	0.003	CcSEcCtD
Risperidone—Pain in extremity—Thalidomide—leprosy	0.000633	0.003	CcSEcCtD
Risperidone—Osteoarthritis—Thalidomide—leprosy	0.000633	0.003	CcSEcCtD
Risperidone—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000633	0.003	CcSEcCtD
Risperidone—HTR1B—nervous system—leprosy	0.00063	0.00662	CbGeAlD
Risperidone—Disturbance in sexual arousal—Thalidomide—leprosy	0.000628	0.00298	CcSEcCtD
Risperidone—Affect lability—Thalidomide—leprosy	0.000623	0.00296	CcSEcCtD
Risperidone—Migraine—Thalidomide—leprosy	0.000623	0.00296	CcSEcCtD
Risperidone—Psychotic disorder—Thalidomide—leprosy	0.000618	0.00293	CcSEcCtD
Risperidone—Face oedema—Thalidomide—leprosy	0.000611	0.0029	CcSEcCtD
Risperidone—HTR1D—nervous system—leprosy	0.00061	0.00641	CbGeAlD
Risperidone—HTR2C—nervous system—leprosy	0.000604	0.00634	CbGeAlD
Risperidone—Cardiac arrest—Thalidomide—leprosy	0.000602	0.00286	CcSEcCtD
Risperidone—Mood swings—Thalidomide—leprosy	0.0006	0.00285	CcSEcCtD
Risperidone—HTR7—tendon—leprosy	0.000598	0.00628	CbGeAlD
Risperidone—Ataxia—Thalidomide—leprosy	0.000595	0.00282	CcSEcCtD
Risperidone—Tachycardia—Dapsone—leprosy	0.000593	0.00281	CcSEcCtD
Risperidone—Dehydration—Thalidomide—leprosy	0.000589	0.00279	CcSEcCtD
Risperidone—Dry skin—Thalidomide—leprosy	0.00058	0.00275	CcSEcCtD
Risperidone—Orthostatic hypotension—Thalidomide—leprosy	0.000578	0.00274	CcSEcCtD
Risperidone—Hypokalaemia—Thalidomide—leprosy	0.000576	0.00273	CcSEcCtD
Risperidone—Breast disorder—Thalidomide—leprosy	0.000572	0.00271	CcSEcCtD
Risperidone—Aspartate aminotransferase increased—Thalidomide—leprosy	0.00057	0.0027	CcSEcCtD
Risperidone—HTR2B—nervous system—leprosy	0.000568	0.00596	CbGeAlD
Risperidone—HTR2A—eye—leprosy	0.000563	0.00591	CbGeAlD
Risperidone—Muscular weakness—Thalidomide—leprosy	0.000558	0.00265	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Thalidomide—leprosy	0.000558	0.00265	CcSEcCtD
Risperidone—Abdominal distension—Thalidomide—leprosy	0.000551	0.00261	CcSEcCtD
Risperidone—Insomnia—Dapsone—leprosy	0.00055	0.00261	CcSEcCtD
Risperidone—ADRA2C—tendon—leprosy	0.00055	0.00577	CbGeAlD
Risperidone—Dysphagia—Thalidomide—leprosy	0.000547	0.0026	CcSEcCtD
Risperidone—Influenza—Thalidomide—leprosy	0.000547	0.0026	CcSEcCtD
Risperidone—Bronchospasm—Thalidomide—leprosy	0.000538	0.00255	CcSEcCtD
Risperidone—Pancreatitis—Thalidomide—leprosy	0.000537	0.00255	CcSEcCtD
Risperidone—Angina pectoris—Thalidomide—leprosy	0.000533	0.00253	CcSEcCtD
Risperidone—Bronchitis—Thalidomide—leprosy	0.000526	0.0025	CcSEcCtD
Risperidone—Neutropenia—Thalidomide—leprosy	0.000512	0.00243	CcSEcCtD
Risperidone—Upper respiratory tract infection—Thalidomide—leprosy	0.000509	0.00241	CcSEcCtD
Risperidone—HTR1A—nervous system—leprosy	0.000509	0.00534	CbGeAlD
Risperidone—Pollakiuria—Thalidomide—leprosy	0.000506	0.0024	CcSEcCtD
Risperidone—Erectile dysfunction—Thalidomide—leprosy	0.000504	0.00239	CcSEcCtD
Risperidone—Photosensitivity reaction—Thalidomide—leprosy	0.000499	0.00237	CcSEcCtD
Risperidone—Weight increased—Thalidomide—leprosy	0.000498	0.00236	CcSEcCtD
Risperidone—Gastrointestinal pain—Dapsone—leprosy	0.000497	0.00236	CcSEcCtD
Risperidone—HTR7—testis—leprosy	0.000495	0.0052	CbGeAlD
Risperidone—Weight decreased—Thalidomide—leprosy	0.000495	0.00235	CcSEcCtD
Risperidone—Hyperglycaemia—Thalidomide—leprosy	0.000494	0.00234	CcSEcCtD
Risperidone—Pneumonia—Thalidomide—leprosy	0.000491	0.00233	CcSEcCtD
Risperidone—Infestation NOS—Thalidomide—leprosy	0.000488	0.00231	CcSEcCtD
Risperidone—Infestation—Thalidomide—leprosy	0.000488	0.00231	CcSEcCtD
Risperidone—Drowsiness—Thalidomide—leprosy	0.000488	0.00231	CcSEcCtD
Risperidone—Depression—Thalidomide—leprosy	0.000487	0.00231	CcSEcCtD
Risperidone—HTR7—nervous system—leprosy	0.000486	0.0051	CbGeAlD
Risperidone—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000484	0.00229	CcSEcCtD
Risperidone—Acute coronary syndrome—Thalidomide—leprosy	0.000481	0.00228	CcSEcCtD
Risperidone—Abdominal pain—Dapsone—leprosy	0.000481	0.00228	CcSEcCtD
Risperidone—Body temperature increased—Dapsone—leprosy	0.000481	0.00228	CcSEcCtD
Risperidone—Renal failure—Thalidomide—leprosy	0.00048	0.00228	CcSEcCtD
Risperidone—Neuropathy peripheral—Thalidomide—leprosy	0.000478	0.00227	CcSEcCtD
Risperidone—Myocardial infarction—Thalidomide—leprosy	0.000478	0.00227	CcSEcCtD
Risperidone—Stomatitis—Thalidomide—leprosy	0.000476	0.00226	CcSEcCtD
Risperidone—Conjunctivitis—Thalidomide—leprosy	0.000474	0.00225	CcSEcCtD
Risperidone—ADRA1A—nervous system—leprosy	0.000469	0.00492	CbGeAlD
Risperidone—DRD2—testis—leprosy	0.000468	0.00492	CbGeAlD
Risperidone—Sweating—Thalidomide—leprosy	0.000468	0.00222	CcSEcCtD
Risperidone—Haematuria—Thalidomide—leprosy	0.000465	0.00221	CcSEcCtD
Risperidone—KCNH2—testis—leprosy	0.000461	0.00484	CbGeAlD
Risperidone—Epistaxis—Thalidomide—leprosy	0.00046	0.00218	CcSEcCtD
Risperidone—DRD2—nervous system—leprosy	0.00046	0.00482	CbGeAlD
Risperidone—Sinusitis—Thalidomide—leprosy	0.000458	0.00217	CcSEcCtD
Risperidone—Agranulocytosis—Thalidomide—leprosy	0.000455	0.00216	CcSEcCtD
Risperidone—ADRA2C—testis—leprosy	0.000455	0.00478	CbGeAlD
Risperidone—KCNH2—nervous system—leprosy	0.000453	0.00475	CbGeAlD
Risperidone—ADRA2C—nervous system—leprosy	0.000447	0.00469	CbGeAlD
Risperidone—HRH1—tendon—leprosy	0.000447	0.00469	CbGeAlD
Risperidone—Bradycardia—Thalidomide—leprosy	0.000446	0.00212	CcSEcCtD
Risperidone—Rhinitis—Thalidomide—leprosy	0.000439	0.00208	CcSEcCtD
Risperidone—ADRA2A—tendon—leprosy	0.000439	0.00461	CbGeAlD
Risperidone—Hepatitis—Thalidomide—leprosy	0.000438	0.00208	CcSEcCtD
Risperidone—Hypoaesthesia—Thalidomide—leprosy	0.000436	0.00207	CcSEcCtD
Risperidone—Pharyngitis—Thalidomide—leprosy	0.000435	0.00206	CcSEcCtD
Risperidone—Urinary tract disorder—Thalidomide—leprosy	0.000433	0.00205	CcSEcCtD
Risperidone—Oedema peripheral—Thalidomide—leprosy	0.000431	0.00205	CcSEcCtD
Risperidone—Urethral disorder—Thalidomide—leprosy	0.000429	0.00204	CcSEcCtD
Risperidone—Visual impairment—Thalidomide—leprosy	0.000422	0.002	CcSEcCtD
Risperidone—Erythema multiforme—Thalidomide—leprosy	0.000414	0.00196	CcSEcCtD
Risperidone—Eye disorder—Thalidomide—leprosy	0.000409	0.00194	CcSEcCtD
Risperidone—Tinnitus—Thalidomide—leprosy	0.000408	0.00194	CcSEcCtD
Risperidone—Cardiac disorder—Thalidomide—leprosy	0.000407	0.00193	CcSEcCtD
Risperidone—Angiopathy—Thalidomide—leprosy	0.000397	0.00189	CcSEcCtD
Risperidone—Immune system disorder—Thalidomide—leprosy	0.000396	0.00188	CcSEcCtD
Risperidone—Mediastinal disorder—Thalidomide—leprosy	0.000395	0.00187	CcSEcCtD
Risperidone—Chills—Thalidomide—leprosy	0.000393	0.00186	CcSEcCtD
Risperidone—Arrhythmia—Thalidomide—leprosy	0.000391	0.00186	CcSEcCtD
Risperidone—Alopecia—Thalidomide—leprosy	0.000387	0.00184	CcSEcCtD
Risperidone—Vomiting—Dapsone—leprosy	0.000386	0.00183	CcSEcCtD
Risperidone—Mental disorder—Thalidomide—leprosy	0.000384	0.00182	CcSEcCtD
Risperidone—Malnutrition—Thalidomide—leprosy	0.000381	0.00181	CcSEcCtD
Risperidone—Headache—Dapsone—leprosy	0.000381	0.00181	CcSEcCtD
Risperidone—Flatulence—Thalidomide—leprosy	0.000376	0.00178	CcSEcCtD
Risperidone—Tension—Thalidomide—leprosy	0.000374	0.00178	CcSEcCtD
Risperidone—Dysgeusia—Thalidomide—leprosy	0.000373	0.00177	CcSEcCtD
Risperidone—HTR2A—tendon—leprosy	0.000373	0.00392	CbGeAlD
Risperidone—Nervousness—Thalidomide—leprosy	0.00037	0.00176	CcSEcCtD
Risperidone—HRH1—testis—leprosy	0.00037	0.00388	CbGeAlD
Risperidone—Back pain—Thalidomide—leprosy	0.000369	0.00175	CcSEcCtD
Risperidone—Muscle spasms—Thalidomide—leprosy	0.000367	0.00174	CcSEcCtD
Risperidone—ADRA2A—testis—leprosy	0.000363	0.00381	CbGeAlD
Risperidone—HRH1—nervous system—leprosy	0.000363	0.00381	CbGeAlD
Risperidone—Nausea—Dapsone—leprosy	0.000361	0.00171	CcSEcCtD
Risperidone—Vision blurred—Thalidomide—leprosy	0.000359	0.0017	CcSEcCtD
Risperidone—Tremor—Thalidomide—leprosy	0.000357	0.00169	CcSEcCtD
Risperidone—ADRA2A—nervous system—leprosy	0.000356	0.00374	CbGeAlD
Risperidone—Ill-defined disorder—Thalidomide—leprosy	0.000354	0.00168	CcSEcCtD
Risperidone—Anaemia—Thalidomide—leprosy	0.000352	0.00167	CcSEcCtD
Risperidone—Agitation—Thalidomide—leprosy	0.00035	0.00166	CcSEcCtD
Risperidone—Angioedema—Thalidomide—leprosy	0.000348	0.00165	CcSEcCtD
Risperidone—Malaise—Thalidomide—leprosy	0.000344	0.00163	CcSEcCtD
Risperidone—Vertigo—Thalidomide—leprosy	0.000343	0.00163	CcSEcCtD
Risperidone—Syncope—Thalidomide—leprosy	0.000342	0.00162	CcSEcCtD
Risperidone—Leukopenia—Thalidomide—leprosy	0.000341	0.00162	CcSEcCtD
Risperidone—Palpitations—Thalidomide—leprosy	0.000337	0.0016	CcSEcCtD
Risperidone—Loss of consciousness—Thalidomide—leprosy	0.000335	0.00159	CcSEcCtD
Risperidone—Cough—Thalidomide—leprosy	0.000333	0.00158	CcSEcCtD
Risperidone—Convulsion—Thalidomide—leprosy	0.00033	0.00157	CcSEcCtD
Risperidone—Hypertension—Thalidomide—leprosy	0.000329	0.00156	CcSEcCtD
Risperidone—Myalgia—Thalidomide—leprosy	0.000325	0.00154	CcSEcCtD
Risperidone—Arthralgia—Thalidomide—leprosy	0.000325	0.00154	CcSEcCtD
Risperidone—Chest pain—Thalidomide—leprosy	0.000325	0.00154	CcSEcCtD
Risperidone—Anxiety—Thalidomide—leprosy	0.000323	0.00153	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000322	0.00153	CcSEcCtD
Risperidone—Discomfort—Thalidomide—leprosy	0.000321	0.00152	CcSEcCtD
Risperidone—Dry mouth—Thalidomide—leprosy	0.000317	0.00151	CcSEcCtD
Risperidone—Confusional state—Thalidomide—leprosy	0.000314	0.00149	CcSEcCtD
Risperidone—Oedema—Thalidomide—leprosy	0.000311	0.00148	CcSEcCtD
Risperidone—Infection—Thalidomide—leprosy	0.000309	0.00147	CcSEcCtD
Risperidone—HTR2A—testis—leprosy	0.000309	0.00324	CbGeAlD
Risperidone—Shock—Thalidomide—leprosy	0.000306	0.00145	CcSEcCtD
Risperidone—Nervous system disorder—Thalidomide—leprosy	0.000305	0.00145	CcSEcCtD
Risperidone—Thrombocytopenia—Thalidomide—leprosy	0.000305	0.00145	CcSEcCtD
Risperidone—Tachycardia—Thalidomide—leprosy	0.000304	0.00144	CcSEcCtD
Risperidone—HTR2A—nervous system—leprosy	0.000303	0.00318	CbGeAlD
Risperidone—Skin disorder—Thalidomide—leprosy	0.000302	0.00143	CcSEcCtD
Risperidone—Hyperhidrosis—Thalidomide—leprosy	0.000301	0.00143	CcSEcCtD
Risperidone—Anorexia—Thalidomide—leprosy	0.000297	0.00141	CcSEcCtD
Risperidone—Hypotension—Thalidomide—leprosy	0.000291	0.00138	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Thalidomide—leprosy	0.000284	0.00135	CcSEcCtD
Risperidone—Insomnia—Thalidomide—leprosy	0.000281	0.00134	CcSEcCtD
Risperidone—CYP2D6—testis—leprosy	0.000281	0.00295	CbGeAlD
Risperidone—CYP3A4—nervous system—leprosy	0.000281	0.00295	CbGeAlD
Risperidone—Paraesthesia—Thalidomide—leprosy	0.000279	0.00133	CcSEcCtD
Risperidone—Dyspnoea—Thalidomide—leprosy	0.000277	0.00132	CcSEcCtD
Risperidone—Somnolence—Thalidomide—leprosy	0.000277	0.00131	CcSEcCtD
Risperidone—CYP2D6—nervous system—leprosy	0.000276	0.0029	CbGeAlD
Risperidone—Dyspepsia—Thalidomide—leprosy	0.000274	0.0013	CcSEcCtD
Risperidone—Decreased appetite—Thalidomide—leprosy	0.000271	0.00128	CcSEcCtD
Risperidone—Gastrointestinal disorder—Thalidomide—leprosy	0.000269	0.00127	CcSEcCtD
Risperidone—Fatigue—Thalidomide—leprosy	0.000268	0.00127	CcSEcCtD
Risperidone—Constipation—Thalidomide—leprosy	0.000266	0.00126	CcSEcCtD
Risperidone—Pain—Thalidomide—leprosy	0.000266	0.00126	CcSEcCtD
Risperidone—Feeling abnormal—Thalidomide—leprosy	0.000256	0.00122	CcSEcCtD
Risperidone—Gastrointestinal pain—Thalidomide—leprosy	0.000254	0.00121	CcSEcCtD
Risperidone—Urticaria—Thalidomide—leprosy	0.000247	0.00117	CcSEcCtD
Risperidone—Body temperature increased—Thalidomide—leprosy	0.000246	0.00117	CcSEcCtD
Risperidone—Abdominal pain—Thalidomide—leprosy	0.000246	0.00117	CcSEcCtD
Risperidone—Hypersensitivity—Thalidomide—leprosy	0.000229	0.00109	CcSEcCtD
Risperidone—Asthenia—Thalidomide—leprosy	0.000223	0.00106	CcSEcCtD
Risperidone—Pruritus—Thalidomide—leprosy	0.00022	0.00104	CcSEcCtD
Risperidone—Diarrhoea—Thalidomide—leprosy	0.000213	0.00101	CcSEcCtD
Risperidone—Dizziness—Thalidomide—leprosy	0.000206	0.000976	CcSEcCtD
Risperidone—ABCB1—testis—leprosy	0.000202	0.00212	CbGeAlD
Risperidone—ABCB1—nervous system—leprosy	0.000199	0.00209	CbGeAlD
Risperidone—Vomiting—Thalidomide—leprosy	0.000198	0.000939	CcSEcCtD
Risperidone—Rash—Thalidomide—leprosy	0.000196	0.000931	CcSEcCtD
Risperidone—Dermatitis—Thalidomide—leprosy	0.000196	0.00093	CcSEcCtD
Risperidone—Headache—Thalidomide—leprosy	0.000195	0.000925	CcSEcCtD
Risperidone—Nausea—Thalidomide—leprosy	0.000185	0.000877	CcSEcCtD
